Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today anno ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...

The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

"We have been slow in finding solutions for preventing infections from intravenous catheters," said Althumayri. "A reason could be that we lack good platforms to test new catheter designs or ...

The publisher has been closely monitoring the various markets in Saudi Arabia. This report provides a comprehensive analysis, detailing market size, forecast, trends, growth drivers, and challenges.